Basophil FcɛRI histamine release parallels expression of Src-homology 2–containing inositol phosphatases in chronic idiopathic urticaria
暂无分享,去创建一个
S. Saini | Hyeyoun Chang | B. Vonakis | S. Gibbons | L. Gober | P. Sterba | K. Vasagar
[1] Suephy C. Chen,et al. Basophil histamine release activity and disease severity in chronic idiopathic urticaria. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[2] S. Saini,et al. Evidence of in vivo basophil activation in chronic idiopathic urticaria , 2006 .
[3] Suephy C. Chen,et al. Basophil Histamine Release (HR) Activity and Disease Severity in Chronic Idiopathic Urticaria (CIU) , 2006 .
[4] Yijie Wang,et al. The inositol phosphatase SHIP-2 down-regulates FcgammaR-mediated phagocytosis in murine macrophages independently of SHIP-1. , 2006, Blood.
[5] K. Chichester,et al. Regulation of Rat Basophilic Leukemia-2H3 Mast Cell Secretion by a Constitutive Lyn Kinase Interaction with the High Affinity IgE Receptor (FcεRI)1 , 2005, The Journal of Immunology.
[6] A. Kaplan,et al. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. , 2005, The Journal of allergy and clinical immunology.
[7] M. Manfredi,et al. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. , 2005, Clinical immunology.
[8] A. Kaplan. Chronic urticaria: pathogenesis and treatment. , 2004, The Journal of allergy and clinical immunology.
[9] G. Krystal,et al. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. , 2004, Immunity.
[10] S. Saini,et al. Relationship between Syk protein and degranulation in basophils from chronic urticaria donors , 2004 .
[11] G. Krystal,et al. SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide. , 2003, Experimental hematology.
[12] C. Marsh,et al. SHIP-2 Inositol Phosphatase Is Inducibly Expressed in Human Monocytes and Serves to Regulate Fcγ Receptor-mediated Signaling* , 2003, Journal of Biological Chemistry.
[13] G. Mills,et al. Targeting PI3K-AKT pathway for cancer therapy. , 2003, Reviews in clinical and experimental hematology.
[14] G. Krystal,et al. Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP , 2002, Nature Cell Biology.
[15] E. Fiebiger,et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. , 2002, The Journal of allergy and clinical immunology.
[16] G. Krystal,et al. Of mice and men: elucidating the role of SH2-containing inositol 5-phosphatase (SHIP) in human disease. , 2002, Clinical and investigative medicine. Medecine clinique et experimentale.
[17] A. Kay,et al. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. , 2002, The Journal of allergy and clinical immunology.
[18] D. MacGlashan,et al. Localizing a Control Region in the Pathway to Leukotriene C4 Secretion Following Stimulation of Human Basophils with Anti-IgE Antibody1 , 2001, The Journal of Immunology.
[19] J. Langdon,et al. Src homology 2 domain-containing inositol 5' phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. , 2001, The Journal of allergy and clinical immunology.
[20] C. Grattan. Basophils in chronic urticaria. , 2001, The journal of investigative dermatology. Symposium proceedings.
[21] A. Kaplan,et al. Mechanisms of autoimmune activation of basophils in chronic urticaria. , 2001, The Journal of allergy and clinical immunology.
[22] C. Wofsy,et al. Expression and modulation of Fc?RIa and Fc?RI in human blood basophils , 2001 .
[23] D. MacGlashan,et al. The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils. , 2000, American journal of respiratory cell and molecular biology.
[24] D. Lucas,et al. Structure, function, and biology of SHIP proteins. , 2000, Genes & development.
[25] J. Oliver,et al. Syk deficiency in nonreleaser basophils. , 1999, The Journal of allergy and clinical immunology.
[26] B. Goldstein,et al. One lyn molecule is sufficient to initiate phosphorylation of aggregated high-affinity IgE receptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Black,et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. , 1999, The Journal of allergy and clinical immunology.
[28] A. Black,et al. Anti-FcϵRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria☆☆☆★★★♢ , 1998 .
[29] M. Huber,et al. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Kinet,et al. Comparative studies of functional and binding assays for IgG anti-FcϵRIα (α-subunit) in chronic urticaria ☆ ☆☆ ★ ★★ , 1998 .
[31] C. Grattan,et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[32] A. Togias,et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. , 1997, Journal of immunology.
[33] T. Rafnar,et al. Molecular identification of an IgE-dependent histamine-releasing factor. , 1995, Science.
[34] J. Kochan,et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. , 1993, The New England journal of medicine.
[35] D. MacGlashan. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. , 1993, The Journal of allergy and clinical immunology.
[36] A. Kaplan,et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. , 1988, The Journal of investigative dermatology.
[37] L. Lichtenstein,et al. Defective histamine release in chronic urticaria. , 1976, The Journal of clinical investigation.
[38] H. Gilbert,et al. Basophil counting with a new staining method using alcian blue. , 1975, Blood.
[39] R. Siraganian. Refinements in the automated fluorometric histamine analysis system. , 1975, Journal of immunological methods.
[40] A. Kaplan,et al. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. , 2002, The Journal of allergy and clinical immunology.
[41] S. Miescher,et al. Natural anti-FcεRIα autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils , 2001 .
[42] E. Fiebiger,et al. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. , 1998, The Journal of clinical investigation.